Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone

<div>Immunohistochemical staining of bone marrow after R-THPCOP. (a) May Grunwald–Giemsa staining (×1000). (b) CD20 (×40). (c) CD138 (×40). White arrow: normal-sized plasma cell; double arrow: large-sized plasma cell.</div>

Case Reports in Hematology

fig6

Figure 6

Figure 6: Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 

Figure 6 | Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 